163 related articles for article (PubMed ID: 23002208)
21. Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer.
Nitzsche B; Gloesenkamp C; Schrader M; Hoffmann B; Zengerling F; Balabanov S; Honecker F; Höpfner M
Br J Cancer; 2012 Nov; 107(11):1853-63. PubMed ID: 23169338
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro.
Koch S; Mayer F; Honecker F; Schittenhelm M; Bokemeyer C
Br J Cancer; 2003 Dec; 89(11):2133-9. PubMed ID: 14647149
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-302a sensitizes testicular embryonal carcinoma cells to cisplatin-induced cell death.
Liu L; Lian J; Zhang H; Tian H; Liang M; Yin M; Sun F
J Cell Physiol; 2013 Dec; 228(12):2294-304. PubMed ID: 23625774
[TBL] [Abstract][Full Text] [Related]
24. An Akt/hypoxia-inducible factor-1alpha/platelet-derived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells.
Lau CK; Yang ZF; Ho DW; Ng MN; Yeoh GC; Poon RT; Fan ST
Clin Cancer Res; 2009 May; 15(10):3462-71. PubMed ID: 19447872
[TBL] [Abstract][Full Text] [Related]
25. Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent.
Piulats JM; Vidal A; García-Rodríguez FJ; Muñoz C; Nadal M; Moutinho C; Martínez-Iniesta M; Mora J; Figueras A; Guinó E; Padullés L; Aytés À; Molleví DG; Puertas S; Martínez-Fernández C; Castillo W; Juliachs M; Moreno V; Muñoz P; Stefanovic M; Pujana MA; Condom E; Esteller M; Germà JR; Capella G; Farré L; Morales A; Viñals F; García-Del-Muro X; Cerón J; Villanueva A
Clin Cancer Res; 2018 Aug; 24(15):3755-3766. PubMed ID: 29618620
[No Abstract] [Full Text] [Related]
26. Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo.
Blomberg Jensen M; Jørgensen A; Nielsen JE; Steinmeyer A; Leffers H; Juul A; Rajpert-De Meyts E
Neoplasia; 2012 Oct; 14(10):952-63. PubMed ID: 23097629
[TBL] [Abstract][Full Text] [Related]
27. Growth and Differentiation Factor 3 Is Transcriptionally Regulated by OCT4 in Human Embryonic Carcinoma Cells.
Han MH; Park SW; Do HJ; Chung HJ; Song H; Kim JH; Kim NH; Park KH; Kim JH
Biol Pharm Bull; 2016; 39(11):1802-1808. PubMed ID: 27803451
[TBL] [Abstract][Full Text] [Related]
28. Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines.
Schmidtova S; Kalavska K; Liskova V; Plava J; Miklikova S; Kucerova L; Matuskova M; Rojikova L; Cierna Z; Rogozea A; Konig H; Albany C; Mego M; Chovanec M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923996
[TBL] [Abstract][Full Text] [Related]
29. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
Spierings DC; de Vries EG; Vellenga E; de Jong S
Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
[TBL] [Abstract][Full Text] [Related]
30. Molecular Mechanisms of Cisplatin Chemoresistance and Its Circumventing in Testicular Germ Cell Tumors.
Schmidtova S; Kalavska K; Kucerova L
Curr Oncol Rep; 2018 Sep; 20(11):88. PubMed ID: 30259297
[TBL] [Abstract][Full Text] [Related]
31. EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors.
Chen KS; Fustino NJ; Shukla AA; Stroup EK; Budhipramono A; Ateek C; Stuart SH; Yamaguchi K; Kapur P; Frazier AL; Lum L; Looijenga LHJ; Laetsch TW; Rakheja D; Amatruda JF
Mol Cancer Ther; 2018 May; 17(5):1079-1089. PubMed ID: 29483210
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of REV7 enhances chemosensitivity and overcomes acquired chemoresistance in testicular germ cell tumors.
Sakurai Y; Ichinoe M; Yoshida K; Nakazato Y; Saito S; Satoh M; Nakada N; Sanoyama I; Umezawa A; Numata Y; Shi-Xu J; Ichihara M; Takahashi M; Murakumo Y
Cancer Lett; 2020 Oct; 489():100-110. PubMed ID: 32553781
[TBL] [Abstract][Full Text] [Related]
33. Expression and roles of system L amino acid transporters in human embryonal carcinoma cells.
Chatsirisupachai K; Kitdumrongthum S; Panvongsa W; Janpipatkul K; Worakitchanon W; Lertjintanakit S; Wongtrakoongate P; Chairoungdua A
Andrology; 2020 Nov; 8(6):1844-1858. PubMed ID: 32741077
[TBL] [Abstract][Full Text] [Related]
34. ErbBs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor.
Juliachs M; Castillo-Ávila W; Vidal A; Piulats JM; Garcia Del Muro X; Condom E; Hernández-Losa J; Teixidó C; Pandiella A; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F
Int J Cancer; 2013 Jul; 133(1):235-46. PubMed ID: 23292912
[TBL] [Abstract][Full Text] [Related]
35. Will Testicular Germ Cell Tumors Remain Untargetable?
Aoun F; Kourie HR; Albisinni S; Roumeguère T
Target Oncol; 2016 Dec; 11(6):711-721. PubMed ID: 27184492
[TBL] [Abstract][Full Text] [Related]
36. OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy.
Sung MT; Jones TD; Beck SD; Foster RS; Cheng L
Hum Pathol; 2006 Jun; 37(6):662-7. PubMed ID: 16733205
[TBL] [Abstract][Full Text] [Related]
37. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.
Bremmer F; Schallenberg S; Jarry H; Küffer S; Kaulfuss S; Burfeind P; Strauß A; Thelen P; Radzun HJ; Ströbel P; Honecker F; Behnes CL
Oncotarget; 2015 Oct; 6(32):33426-37. PubMed ID: 26451610
[TBL] [Abstract][Full Text] [Related]
38. Activity of nintedanib in germ cell tumors.
Steinemann G; Jacobsen C; Gerwing M; Hauschild J; von Amsberg G; Höpfner M; Nitzsche B; Honecker F
Anticancer Drugs; 2016 Feb; 27(2):89-98. PubMed ID: 26479145
[TBL] [Abstract][Full Text] [Related]
39. Potent antitumor activity of Oct4 and hypoxia dual-regulated oncolytic adenovirus against bladder cancer.
Lu CS; Hsieh JL; Lin CY; Tsai HW; Su BH; Shieh GS; Su YC; Lee CH; Chang MY; Wu CL; Shiau AL
Gene Ther; 2015 Apr; 22(4):305-15. PubMed ID: 25588741
[TBL] [Abstract][Full Text] [Related]
40. CIP2A is an Oct4 target gene involved in head and neck squamous cell cancer oncogenicity and radioresistance.
Ventelä S; Sittig E; Mannermaa L; Mäkelä JA; Kulmala J; Löyttyniemi E; Strauss L; Cárpen O; Toppari J; Grénman R; Westermarck J
Oncotarget; 2015 Jan; 6(1):144-58. PubMed ID: 25474139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
